Litigation

Recent Posts

11th Circuit Affirms Exclusion Of Plaintiff Expert In First Seroquel Bellwether
Posted on 7 Apr 2010 by Tom Moylan

ATLANTA — (Mealey’s) The sole causation expert for the first bellwether plaintiff in the Seroquel multidistrict litigation failed to rule out other causes of weight gain and diabetes, a panel of the 11th Circuit U.S. Court of Appeals said... Read More

Tags: Linda Guinn v. AstraZeneca Pharmaceuticals LP , Daubert v. Merrill Dow Pharmaceuticals , emerging drugs & devices , expert admissibility , 11th Circuit U.S. Court of Appeals , Litigation , Liknda Guinn , AstraZeneca Pharmaceuticals , Daubert , torts , Seroquel

William A. Ruskin: Daubert On The Defense?
Posted on 6 Jun 2012 by William A. Ruskin

By William A. Ruskin We discussed in an earlier article how the Reference Manual for Scientific Evidence , published by the Federal Judicial Center, has become an indispensable tool for judges in managing cases involving complex scientific and technical... Read More

Tags: Jessalyn H. Zeigler , IADC , Daubert v. Merrill Dow Pharmaceuticals , Changes in the Reference Manual on Scientific Evidence (3rd Ed.) , Federal Rule of Evidence 702 , Reference Manual On Scientific Evidence , Milward v. Acuity Specialty Products Group , Co. , electric , Bruce R. Parker , William A. Ruskin , Litigation , James W. Shelson , RMSE Third , Joiner' , Daubert , Inc , Reference Manual on Scientific Evidence: Third Edition , James F. Rogers , expert witnesses